OneOncology launches OneR, precision oncology research network

By The Science Advisory Board staff writers

October 19, 2020 -- OneOncology has formed a subsidiary named OneOncology Research Network (OneR) as a national nonexclusive clinical trial site management organization to enhance research programs underway at participating community oncology practices.

The organization will provide operational, regulatory and research support services to more efficiently execute multicenter clinical trials. OneR will enhance a practice's ability to increase clinical trial participation by centralizing business functions, regulatory submissions, and clinical trial matching technology.

The OneR platform will increase practices' access to innovative therapies for their patients. The network will also provide trial sponsors with diverse populations of patients. OneR ensures diversity in clinical trial participation including ethnicity, gender, geography, disease status, socioeconomics, and various other dimensions.

OneR will focus on precision oncology to offer clinical trials across tumor types with innovative trial designs like basket and umbrella trials. A basket trial tests how well a new drug works in patients who have different types of cancer that all have the same mutation or biomarker. In umbrella trials, patients with one specific cancer receive treatment based on the molecular profile of their individual cancer.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.